The prevalence of bacterial overgrowth syndrome and its associated factors in patients with inflammatory bowel diseases (according to the data of the Novosibirsk registry)
- Authors: Kulygina Y.A1, Osipenko MF1, Skalinskaya MI1, Palchunova KD1
-
Affiliations:
- Новосибирский государственный медицинский университет Минздрава России
- Issue: Vol 89, No 2 (2017)
- Pages: 15-19
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32151
- DOI: https://doi.org/10.17116/terarkh201789215-19
- ID: 32151
Cite item
Full Text
Abstract
Aim. To assess the prevalence of bacterial overgrowth syndrome (BOS) and its risk factors in patients with inflammatory bowel diseases (IBD). Subjects and methods. The patients from the Novosibirsk IBD registry, who had undergone a hydrogen breath test (HBT) using a Gastro+ device, were examined. Results. In 93 IBD patients who had undergone a HBD, the prevalence of BOS was 48% (46.2% for ulcerative colitis and 51.2% for Crohn’s disease). There was a strong correlation between abdominal bloating, abdominal rumbling, and positive HBT results in both patient groups. During the HBT, the patients with BOS frequently complained of diarrhea, borborygmi, belching, and anxiety. Conclusion. The findings suggest that BOS is highly prevalent among patients with IBD. BOS is associated with clinical symptoms, such as abdominal bloating, abdominal rumbling, tearfulness, and irritability.
Full Text
##article.viewOnOriginalSite##About the authors
Yu A Kulygina
Новосибирский государственный медицинский университет Минздрава РоссииНовосибирск, Россия
M F Osipenko
Новосибирский государственный медицинский университет Минздрава РоссииНовосибирск, Россия
M I Skalinskaya
Новосибирский государственный медицинский университет Минздрава РоссииНовосибирск, Россия
K D Palchunova
Новосибирский государственный медицинский университет Минздрава РоссииНовосибирск, Россия
References
- Bouhnik Y, Alain S, Attar A, Flourié B, Raskine L, Sanson-Le Pors MJ et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol. 1999;94(5):1327-1331. doi: 10.1111/j.1572-0241.1999.01016
- Осипенко М.Ф., Скалинская М.И., Кулыгина Ю.А., Холин С.И., Краснер Я.А. Что мы знаем о синдроме избыточного бактериального роста. Медицинский Совет. 2016;(9):70-74. doi: 10.21518/2079-701X-2016-9-70-74
- Парфенов А.И., Ручкина И.Н., Осипов Г.А., Калоев Ю.К. Дисбактериоз кишечника: вопросы биологической терапии. Трудный пациент. 2007;5:32-34.
- Scarpellini E, Giorgio V, Gabrielli M, Lauritano EC, Pantanella A, Fundarò C et al Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study. J Pediatr. 2009;155:416-420. doi:org/10.1016/j.jpeds.2009.03.033
- Sabaté JM, Jouët P, Harnois F, Mechler C, Msika S, Grossin M, Coffin B High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg. 2008;18:371-377. doi: 10.1007/s11695-007-9398-2
- Vanderhoof JA, Young RJ. Etiology and pathogenesis of bacterial overgrowth. Clinical manifestations and diagnosis of bacterial overgrowth. Treatment of bacterial overgrowth. UpToDate online, vol 18.1; Wellesley, 2010. Available from: http://www.uptodate.com. doi: 10.1007/978-1-60761-183-7_11
- Scarpellini E, Gabrielli M, Za T, Lauritano EC, Santoliquido A, Rossi E, Ojetti V, Cammarota G De Stefano V, Gasbarrini A. The interaction between small intestinal bacterial overgrowth and warfarin treatment. Am J Gastroenterol. 2009;104:2364-2365. doi: 10.1038/ajg.2009.288
- Fava F, Danese S. Intestinal microbiota in inflammatory bowel disease: Friend of foe? World J Gastroenterol. 2011;17(5): 557-566. doi:org/10.3748/wjg.v17.i5.557
- Michielan A, D’Incà R. Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut. Mediators Inflamm. 2015;2015:628157. doi:org/10.1155/2015/628157
- Antoni L, Nuding S, Wehkamp J, Stange E Intestinal barrier in inflammatory bowel disease. World J Gastroenterol 2014; 20(5): 1165-1179. doi: 10.3748/WJG.v20.i5.1165
- Lee S. Intestinal Permeability Regulation by Tight Junction: Implication on Inflammatory Bowel Diseases. Intest Res. 2015; 13(1):11-18. doi:org/10.5217/ir.2015.13.1.11
- Andrei M, Gologan S, Stoicescu A, Ionescu M, Nicolaie T, Diculescu M Small Intestinal Bacterial Overgrowth Syndrome Prevalence in Romanian Patients with Inflammatory Bowel Disease. Current Health Sciences Journal. 2016;42(2);151-156. doi:org/10.1093/ecco-jcc/jjv215
- Rubio-Tapia A, Barton SH, Rosenblatt JE, Murray JA. Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol. 2009;43:157-161. doi:org/10.1097/mcg.0b013e/3191557e67
- Pande C, Kumar A, Sarin SK. Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Aliment Pharmacol Ther. 2009;29:1273-1281. doi: 10.1111/j.1365-036.2009.03994
- Runyon BA. Pathogenesis of spontaneous bacterial peritonitis. UpToDate on line, 18.1. Wellesley. 2010;1517-1541. doi:org/10.1016/b978-1-4160-6189-2.00091-3
- Ebert EC. The thyroid and the gut. J Clin Gastroenterol. 2010;44:402-406. doi:org/10.1097/mcg.0b013e3181d6bc3e
- Scarpellini E, Giorgio V, Gabrielli M, Lauritano EC, Pantanella A, Fundarò C et al Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study. J Pediatr. 2009;155:416-420. doi:org/10.1016/j.jpeds.2009.03.033
- Swidsinski A, Loening-Baucke V Spatial organization of intestinal microbiota in health and disease. UpToDate on line, 18.1. Wellesley, 2010;214-254. doi:org/10.1002/9781118409855.ch9
- Фадеева Н.А., Ручкина И.Н., Парфенов А.И., Щербаков П.Л.. Избыточный рост микрофлоры тонкой кишки как причина лактазной недостаточности. Тер. архив. 2015;87(2): 20-23. doi: 10.17116/terarkh201587220-23
- Парфенов А.И. Энтерология: Руководство для врачей. 2-е изд. М.: МИА, 2009:108-110.
- Klaus J, Spaniol U, Adler G, Mason RA, Reinshagen M, Tirpitz C. Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn’s Disease. BMC Gastroenterol. 2009;9:61. doi:org/10.1186/1471-230x-9-61
- Sánchez-Montes C, Ortiz V, Bastida G, Rodríguez E, Yago M, Beltrán B et al. Small intestinal bacterial overgrowth in inactive Crohn’s disease: influence of thiopurine and biological treatment. World J Gastroenterol. 2014;20(38):13999-4003. doi:org/10.3748/wjg.v20.i38.13999
![](/img/style/loading.gif)